Loading clinical trials...
Loading clinical trials...
This multi-centred randomized, open label-controlled trial consists of hemodialysis (HD) patients identified with hyperphosphatemia (\>1.78mmol/L). The intervention group received a phosphate mobile a...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Taylor's University
NCT07285291 · Hyperphosphatemia Patients on Hemodialysis
NCT06933472 · Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, and more
NCT07285304 · Hyperphosphatemia Patients on Hemodialysis
NCT05654103 · End Stage Renal Disease on Dialysis
NCT03573089 · Kidney Failure, Chronic, Hyperphosphatemia
Pusat Rawatan Dialisis Islah
Batu Caves, Selangor
National Kidney Foundation Malaysia
Petaling Jaya, Selangor
Hospital Kuala Lumpur
Kuala Lumpur
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions